Conference Reports for NATAP

64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013 Back

Twice Daily Telaprevir in Combination with Peginterferon Alfa-2a/Ribavirin in Genotype 1 HCV Liver Transplant Recipients: Interim Week 16 Calcineurin Inhibitor, Telaprevir, and Ribavirin Pharmacokinetics From the Prospective Multicenter REFRESH Study       Reported by Jules Levin AASLD 2013 Nov 1-5 Wash DC   Robert J Fontana et al